Skip to content
Stock screener

CAH Cardinal Health Inc stock chart & analysis

Conviction 25HealthcareScan · Fri, Nov 6, 2026

Cardinal Health Inc (CAH) closed at $271.72 (+1.46%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 74, RS Rating 93, -5.0% from its 52-week high, +32.3% year to date. Sector: Healthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries.

CAH$271.72+1.46%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Cardinal Health IncWholesale-Drugs, Proprietaries & Druggists' Sundrieswww.cardinalhealth.com ↗
Price271.72
Change+1.46%
Gap-0.65%
Rel volume0.65×
Avg volume1.84M
Avg $ vol465.85M
SMA 20252.97
SMA 50240.49
SMA 200223.44
Price vs 50+13.08%
Price vs 200+21.71%
MA stackbullish
50/200 cross—
Supertrendup · 253.03
RSI (14)74
MACD hist1.50
MACD crossbull · 2d
Stoch %K / %D67 / 74
ADX (14)28
+DI / −DI46 / 15
RSI divergence—
MACD divergence—
ATR %2.72%
ADR %2.50%
52w high286.29
52w low180.45
From 52w high-5.01%
Above 52w low+50.71%
New 52w highYes
SqueezeOff
Bollinger width12.60%
%B1.10
Donchian pos72.64%
Donchian high286.29
Donchian low233.88
AVWAP (52w high)272.72
vs AVWAP high-0.28%
AVWAP (52w low)229.04
vs AVWAP low+18.73%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d0.65×
Avg vol (14d)1.78M
Avg vol (20d)1.84M
Avg $ vol (20d)465.85M
Market cap62.86B
RS Rating93 / 99
RS 3m (vs SPY)+19.53%
RS 6m (vs SPY)+48.38%
RS line new highYes
Trend template8/8
Technical rank95.4
1 week+8.57%
1 month+13.81%
3 months+14.66%
6 months+48.08%
1 year+38.19%
YTD+32.34%
P/E36.67
P/B-20.78
P/S0.25
P/FCF13.89
EPS7.23
Div yield0.78%
ROE-56.66%
ROA2.88%
Debt/Eq-0.94
Current0.88
EV/EBITDA16.93
Gross margin3.84%
Net margin0.67%
Rev growth14.23%
EPS growth9.80%
Price target284.69
Target upside4.68%
Analyst ratingBuy
Institutional103.91%
Ent. value60.44B
Revenue67.51B
Net income554M
Gross profit2.6B
Free cash flow4.53B
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNYSE
Shares out234.21M
Employees57.7K
ListedThu, Aug 4, 1983
Free float235.03M
Float %99.9%
Short interest—
Days to cover—
Short volume58.1%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$3.26 vs $2.92
Last surprise+11.6% beat
Setup gradeD
Conviction25 / 100
Pattern quality—
Tech rank95.4 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance259.53
Support230.10
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

CAH technical analysis

Trend

CAH is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 13.1% above the 50-day ($240.49) and 21.7% above the 200-day ($223.44). ADX(14) at 28 points to a strong, established trend. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 74, in overbought territory. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 93 puts its weighted 12-month performance ahead of about 93% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 0.6× its 20-day average. It trades about $465.8M a day on average. ATR(14) is $7.40, 2.7% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.08) shows accumulation.

Key levels

The chart pattern's support is $230.10 and its resistance $259.53. The 52-week range is $180.45 to $286.29; price is 5.0% below the high and 50.7% above the low. The VWAP anchored at the 52-week high is $272.72, above price.

Performance

CAH returned +8.6% (1 week), +13.8% (1 month), +14.7% (3 months), +48.1% (6 months), +38.2% (1 year), +32.3% (year to date).

About Cardinal Health Inc

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · Listed 1983 · 57,700 employees

Congress activity

Disclosed STOCK Act trades in CAH · 9 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Marjorie Taylor Greene
Marjorie Taylor Greene
house · GA · traded 2025-10-24
Buy$1K–$15K
Marjorie Taylor Greene
Marjorie Taylor Greene
house · GA · traded 2025-05-14
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Buy$1K–$15K
Marjorie Taylor Greene
Marjorie Taylor Greene
house · GA · traded 2025-05-05
Buy$1K–$15K
Marjorie Taylor Greene
Marjorie Taylor Greene
house · GA · traded 2025-03-17
Buy$1K–$15K
Marjorie Taylor Greene
Marjorie Taylor Greene
house · GA · traded 2025-01-21
Buy$1K–$15K
Marjorie Taylor Mrs Greene
Marjorie Taylor Mrs Greene
house · GA · traded 2024-09-20
Buy$1K–$15K
John James
John James
house · MI · traded 2024-05-02
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CAH · open-market 10 sells

InsiderSideShares
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell3.46K
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell6.21K
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell16.19K
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell6.24K
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell5.7K
Hollar Jason M.
Chief Executive Officer · Common Shares · 2026-08-19
Sell6.73K
Scherer Mary C.
Chief Accounting Officer · Common Shares · 2026-08-19
Sell100
Scherer Mary C.
Chief Accounting Officer · Common Shares · 2026-08-19
Sell2.2K
Alt Aaron E
Chief Financial Officer · Common Shares · 2026-08-18
Sell12.97K
Mayer Jessica L
Chief Legal/Compliance Officer · Common Shares · 2026-08-18
Sell3.9K

SEC filings

EDGAR filings in CAH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.